ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Invites Ad Hoc Consumer Reps To ODAC Meetings

February 17, 1995

NCI Programs: NCI To Study Colorectal Cancer Screening Practices

September 17, 1999

NCI Plans To Recomplete CCOP; Future Direction To Be Discuss At DCPC Board, NCAB Meetings

January 17, 1986

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013